scholarly journals P1.01-32 A Multicenter, Open-Label, Phase II Trial of S-1 Plus Carboplatin in Advanced Non-Small Cell Lung Cancer Patients with Interstitial Lung Disease

2018 ◽  
Vol 13 (10) ◽  
pp. S472
Author(s):  
M. Hanibuchi ◽  
S. Kakiuchi ◽  
S. Atagi ◽  
F. Ogushi ◽  
E. Shimizu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Interstitial Lung Disease ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Open Label ◽  
Lung Cancer Patients ◽  
Open Label Phase

A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide

Lung Cancer ◽  
2014 ◽  
Vol 86 (1) ◽  
pp. 59-66 ◽  
Author(s):  
Athanasios Kotsakis ◽  
Elisavet Papadimitraki ◽  
Eleni Kyriaki Vetsika ◽  
Despoina Aggouraki ◽  
Eleftheria Kleio Dermitzaki ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Immunologic Response ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Cryptic Peptide
Sign in / Sign up

Export Citation Format

Share Document